Eyenuk To Provide Artificial Intelligence (AI) Eye Screening to Thousands of Italians Through Collaboration With Ambrosian Ophthalmic Center in February

EyeArt_Mac_Macbook_Mockups_withlogos_img

– 30 Centers Across Italy Will Provide AI Eye Screening for Diabetic Retinopathy, the Leading Cause of Vision Loss Among Working-age Adults – LOS ANGELES–Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today that it is providing EyeArt® AI Eye […]

Continue Reading »

Eyenuk successfully clears HIPAA audit by A-Lign

A-LIGN-HIPAA Logo- New Brand-02

Eyenuk successfully clears HIPAA audit by A-Lign Eyenuk Inc., a global artificial intelligence (AI) medical technology company, is pleased to announce that it has successfully cleared an independent HIPAA audit. As a leader in real-world AI eye screening for autonomous disease detection, the team at Eyenuk Inc. understands and embraces the responsibility to keep patient […]

Continue Reading »

Eyenuk, Inc. at ARVO 2016 (April 30-May 5)

ARVO_2016_Seattle_Logo

Eyenuk, Inc. will be attending the ARVO 2016 conference in Seattle, Washington from April 30th through May 5th. Eyenuk CEO, Kaushal Solanki, along with Sandeep Bhat, Chaithanya Ramachandra, and Malavika Bhaskaranand will present several posters on Eyenuk’s technology, including EyeArt™ Following is the list of presentations in chronological order Sat, Apr 30, 2016, 10:00-10:30am, Session […]

Continue Reading »

Eyenuk, Inc. granted CE marking for EyeArt

CE_logo_nemko_EyeArt_resized

Eyenuk, Inc. announced today that it received CE Marking for its pioneering EyeArt software, a suite of advanced image analysis tools for automated high-throughput screening of diabetic retinopathy. The company plans to launch its product in selected leading eye-care sites across Europe in the next few months. Diabetic Retinopathy (DR), a common microvascular complication of […]

Continue Reading »